急性肝衰竭病情严重程度评估

doi:10.3969/j.issn.1672-5069.2017.01.006

Abstract

Li Shuang, Chen Yu. You'an.. Severity evaluation of acute liver failure[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(1): 17-20.

[1] 中华医学会感染病学分会肝衰竭与人工肝学组. 肝衰竭诊治指南（2012年版）. 实用肝脏病杂志,2013,7（3）:210-216.
[2] Bernal W,Wendon J. Acute liver failure. New Engl J Med, 2014,370（12）:1170-1171.
[3] Polson J,Lee WM,Disease AAFO. AASLD position paper:the management of acute liver failure:update 2011. Nat Guideline Clearinghouse,2012,65（4）:1433-1441.
[4] Shalimar A,Acharya SK. Management in acute liver failure. J Clin Experiment Hepatol,2015,5（Suppl 1）:104-115.
[5] Lee WM. Acute liver failure. Sem Resp Crit Care Med,2012,33（1）:123-125.
[6] 聂青和. 肝衰竭实验室检测的临床价值及新指标评价. 临床肝胆病杂志,2013,29（9）:666-669.
[7] Wlodzimirow KA,Eslami S,Abu-Hanna A,et al. A systematic review on prognostic indicators of acute liver failure and their predictive value for poor outcome. Bri J Med Med Res,2014,4（4）:2796-2852.
[8] OGrady J. Timing and benefit of liver transplantation in acute liver failure. J Hepatol,2014,60（3）:663-670.
[9] Munoz S J,Stravitz R T,Gabriel D A. Coagulopathy of acute liver failure. Clin Liver Dis,2009,13（1）:95-107.
[10] Merle U,Sieg O,Stremmel W,et al. Sensitivity and specificity of plasma disappearance rate of indocyanine green as a prognostic indicator in acute liver failure. Bmc Gastroenterol,2009,9（1）:1-7.
[11] Ren ZXYZS. Indocyanine green retention test avoiding liver failure after hepatectomy for hepatolithiasis. Hepatogastroenterolog,2012,59（115）:782-784.
[12] Feng H L,Li Q,Wang L,et al. Indocyanine green clearance test combined with MELD score in predicting the short-term prognosis of patients with acute liver failure. Hepatobiliary Pancreat Dis Int,2014,13（3）:271-275.
[13] Rolando N,Wade J,Davalos M,et al. The systemic inflammatory response syndrome in acute liver failure. Hepatology,2000,32（4）:734-739.
[14] Kamath P S,Heimbach J,Wiesner R H. Acute liver failure prognostic scores:Is good enough good enough. Clin Gastroenterol Hepatol,2016,14（4）:621-623.
[15] Stravitz R T,Ellerbe C,Durkalski V,et al. Thrombocytopenia is associated with multi-organ system failure in patients with acute liver failure. Clin Gastroenterol Hepatol,2015,14（4）:613-620.
[16] Rule J A,Hynan L S,Attar N,et al. Procalcitonin identifies cell injury,Not bacterial infection in acute liver failure. Plos One,2015,10（9）:12073.
[17] Antoniades C,Triantafyllou E,Gadhok R,et al. 1013 CD163 is a mechanistic biomarker in acute liver failure reflectiong a macrophage activation like syndrome. J Hepatol,2013,58,（Suppl1）:S417.
[18] MLler HJ,Gr Nbaek H,Schi Dt FV,et al. Soluble CD163 from activated macrophages predicts mortality in acute liver failure. J Hepatol,2007,47（5）:671-676.
[19] Takikawa Y,Suzuki K. Is AFP a new reliable marker of liver regeneration in acute hepatic failure. J Gastroenterol,2002,37（8）:681-682.
[20] Schiodt FV,Ostapowicz G,Murray N,et al. Alpha-fetoprotein and prognosis in acute liver failure. Liver Transplant,2006,12（12）:1776-1781.
[21] Karvellas CJ,Fix OK,Battenhouse H,et al. Outcomes and complications of intracranial pressure monitoring in acute liver failure:a retrospective cohort study. Crit Care Med,2014,42（5）:1157-1167.
[22] Bernal W,Hyyrylainen A,Gera A,et al. Lessons from look-back in acute liver failure A single centre experience of 3300 patients. J Hepatol,2013,59（1）:74-80.
[23] Yamagishi Y,Saito H,Ebinuma H,et al. A new prognostic formula for adult acute liver failure using computer tomography-derived hepatic volumetric analysis. J Gastroenterol, 2009,44（6）:615-623.
[24] Romero M,Palmer SL,Kahn JA,et al. Imaging appearance in acute liver failure:Correlation with clinical and pathology findings. Dig Dis Sci,2014,59（8）:1987-1995.
[25] Ashish Singhal SVKS. Liver histology as predictor of outcome in patients with acute liver failure. Transplant Int,2012,25（6）:658-662.
[26] Mcphail MJW,Wendon JA,Bernal W. Meta-analysis of performance of Kings’s College Hospital Criteria in prediction of outcome in non-paracetamol-induced acute liver failure. J Hepatol,2010,53（3）:492-499.
[27] Craig D G N,Ford A C,Hayes P C,et al. Systematic review: prognostic tests of paracetamol-induced acute liver failure. Aliment Pharmacol Therapeut,2010,31（10）:1064-1076.
[28] Bailey B,Amre D K,Gaudreault P. Fulminant hepatic failure secondary to acetaminophen poisoning:a systematic review and meta-analysis of prognostic criteria determining the need for liver transplantation. Crit Care Med, 2003,31（1）:299-305.

Severity evaluation of acute liver failure

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	patients with chronic hepatitis B Zhang Yingming, Shen Shuang, Tian Fei, et al.. Prediction of response to peginterferon alfa-2a by blood IFNL4 and IL-28B gene polymorphisms in [J]. Journal of Practical Hepatology, 2019, 22(6): 828-831.
[2]	Yang Caiyong, Chen Na, Li Kui, et al.. Clinical significance of peripheral blood Treg and Th17 cells in patients with chronic hepatitis C and hepatitis C-induced liver cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(6): 868-871.
[3]	Zhu Yucheng, Yan Jiawei, Sun Jingkun, et al. Serum diamine oxidase level in patients with hepatitis B-induced acute-on-chronic liver failure [J]. Journal of Practical Hepatology, 2019, 22(5): 672-675.
[4]	Wang Gang, Zhao Hongbo, Zhu Yaling, et al. Cancerous XPO5 gene level in patients with hepatocellular carcinoma and its clinical significance [J]. Journal of Practical Hepatology, 2019, 22(5): 724-727.
[5]	Zhang Xuan, Tang Xiaoyun, Tang Chunyin, et al. Effect of Chinese herbal medicine on intestinal microflora in mice with D-galactosamine/LPS-induced acute liver failure [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 478-481.
[6]	Bai Yichun, Deng Jihong, Mei Xiaoping. Efficacy of peginterferon alfa-2b treatment and affecting response factors in patients with chronic hepatitis B [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 490-493.
[7]	Zhuang Taiping, Yin Yangyan, Xie Manfang, et al. Comparison of clinical features of infants with human cytomegalovirus infection and of infantile hepatitis syndrome [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 514-517.
[8]	Peng Silu, Liu Bing, Sun Hong, et al. Prognosis of patients with hepatitis B-induced acute-on-chronic liver failure [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 545-548.
[9]	Xu Manman, Chen Yu, Li shuang. Predictive value of urinary NGAL and KIM-1 for response of patients with hepatorenal syndrome to terlipressin combined with albumin infusion treatment [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(3): 385-388.
[10]	Zhang Tingting, Wang Xuan. Clinical implications of oral glucose tolerance test in cirrhotic patients with hepatogenous diabetes [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(3): 449-452.
[11]	Gao Pengbin, Zhao Xiaoyan, Qin Hao, Wu Fengying, Zhang Haizhen, Wang Lin, Jia Huina, Li Shujuan. Risk factors for poor prognosis of patients with hepatitis E-induced liver failure [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 220-223.
[12]	Wang Huming, Fan Dongsheng, Xu Jie, Liu Xianfegn, Zhou Ning, Li Min, Bao Nana. Cancerous miRNA-30c levels affecting the survival of patients with hepatocellular carcinoma after hepatectomy [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 248-251.
[13]	Zhang Xiaozhou, Shuai Ling, Wang Qingda, Yang Nan. Changes of serum miR-335 levels in patients with hepatocellular carcinoma undergoing transcatheter arterial chemoembolization [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 268-271.
[14]	Ma Deyuan, Ma Yuanfeng, Zhang Dianlong, et al.. Prognostic efficacy of serum keratin 18 in patients with hepatitis B virus-related acute on chronic liver failure [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(1): 77-80.
[15]	Ma Lyuxiang, Zhang Xuesong.. Efficacy and prognosis of ultrasound-guided percutaneous radiofrequency ablation in treatment of patients with small hepatocellular carcinoma [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(1): 125-128.